Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal CancerPeter S Hall, Pavel Bezecny, Sharon Ruddock et al.|JAMA Oncology|2021Cited by 196
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancerAmit Bahl, Mark Churn, William W. Wilson et al.|The Breast|2022Cited by 7
Randomized multicenter trial of 3 weekly cabazitaxel versus weekly paclitaxel chemotherapy in the first-line treatment of HER2 negative metastatic breast cancer (MBC).Amit Bahl, William Wilson, Jeremy Braybrooke et al.|Journal of Clinical Oncology|2021Cited by 2